A. Chartakov, “THE ROLE OF SERUM CYSTATIN C IN EARLY ASSESSMENT OF RENEAL RISK IN PATIENTS WITH PREDIABETES”, GSCMR, vol. 1, no. 5, pp. 61–66, May 2026, doi: 10.5281/zenodo.20074553.